Quantum Biopharma Announces the Success of unbuzzd™ Clinical Trial
Hangover Relief: Participants in this study noted a statistically significant reduction in hangover symptoms. This included reduced cognitive and physical impairment, and reduced headache compared to ...
Nasdaq6d
Quantum BioPharma Ltd. Announces Positive Results from Clinical Trial of unbuzzd™ Dietary Supplement for Alcohol Intoxication Relief
unbuzzd™ was well-tolerated and safe ... a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential ...
Nasdaq4d
Quantum BioPharma's Licensee Celly Nutrition Engages New York Investment Bank for Capital Raise and Potential IPO
Having successfully launched unbuzzd in the US market in 2024 ... of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured ...
Morningstar6d
Quantum Biopharma Announces the Success of unbuzzd™ Clinical Trial
Results of data analysis show definitively that unbuzzd™ accelerated the rate at which Blood Alcohol Concentration (“BAC”) was reduced in study subjects, while simultaneously reducing the ...
Yahoo Finance5d
Quantum Biopharma Announces the Success of unbuzzd™ Clinical Trial
TORONTO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company ...